Jackson Financial stock rallied in morning trading, climbing 10.35% after Jefferies upgraded the shares to Buy from Hold and raised its price target to $140 from $120. The move pushed the stock as high as $121.05 intraday.
In its reassessment, Jefferies conceded that a downgrade it issued in early 2024 - which had been prompted by concerns that the Brooke Re structure would reduce transparency around risk-based capital - was not the correct call. The bank noted that Jackson Financial's earnings are among the most closely tied to equity market performance within the insurance sector, a factor that amplifies the company's upside as markets strengthen.
Jefferies cited two specific supports for its more bullish stance: the substantial cumulative gains in the S&P 500 since the early-2024 downgrade, which act as a direct tailwind for Jackson Financial's model, and TPG's $500 million strategic investment in the company. These elements, the firm argued, strengthen the investment case.
Adding to the momentum, Barclays recently raised its price target on Jackson Financial to $139 from $136 while maintaining an Overweight rating. That parallel adjustment from another major bank contributed to a broader lift in analyst conviction around the stock heading into the session.
The stock-specific news was the dominant force behind the move. The wider U.S. equity market provided little directional support, with the S&P 500 up roughly 0.1%, the Dow Jones Industrial Average edging about 0.2% higher, and the Nasdaq trading slightly negative. That divergence underscores that the spike in Jackson Financial shares was driven primarily by analyst activity rather than macro market strength.
Investors frequently compare Jackson Financial to peers in the annuities and life insurance space when assessing relative positioning, with names such as Brighthouse Financial and Lincoln National commonly used as benchmarks. The combination of a high-conviction upgrade from Jefferies, a concurrent price-target increase from Barclays, and the insurer's structural sensitivity to equity markets helped propel the stock toward its 52-week high of $123.61, signaling renewed institutional confidence in the company's risk-reward profile.
Clear summary
Jefferies upgraded Jackson Financial to Buy and raised its price target to $140 from $120, acknowledging its earlier downgrade was mistaken. Barclays also increased its target to $139 while keeping an Overweight rating. Together with TPG's $500 million strategic investment and sizable gains in the S&P 500 since the earlier downgrade, these factors drove a company-specific rally that lifted the stock toward its 52-week high.
Key points
- Jefferies upgraded JXN to Buy from Hold and raised its price target to $140 from $120, sending the shares up 10.35% and as high as $121.05 intraday - impacts equity and insurance sectors.
- Barclays raised its price target to $139 from $136 while keeping an Overweight rating, reinforcing improving analyst conviction around the stock - impacts institutional investor sentiment.
- Jefferies highlighted the S&P 500's cumulative gains since the early-2024 downgrade and TPG's $500 million strategic investment as direct tailwinds for Jackson Financial's business model - impacts market-sensitive earnings profiles.
Risks and uncertainties
- Jackson Financial's earnings are highly sensitive to equity market performance, creating exposure to market volatility - relevant to the insurance and broader financial sectors.
- Concerns that prompted Jefferies' early-2024 downgrade centered on the Brooke Re structure reducing risk-based capital transparency; although Jefferies now says that call was incorrect, the underlying transparency issue was a focal point of uncertainty.
- The rally was largely company-specific with limited support from broader U.S. equity indexes, which could leave the stock vulnerable if analyst sentiment shifts or if market conditions change - relevant to investors comparing annuities and life insurance peers.